Overview ZUPREVO™ 18% (tildipirosin) is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in beef and non-lactating dairy cattle, and for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.

  • Subcutaneous injection of 1ml/100lb of tildipirosin
  • For treatment of BRD and control of respiratory disease in beef and non-lactating dairy cattle at "high risk" of developing BRD
  • 21-day pre-slaughter withdrawal period
  • Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian